Purpose: This paper illustrates a conceptual model for a new patient-reported outcome measure (PROM) aimed at measuring financial toxicity (FT) in oncological setting in Italy, where citizens are provided universal healthcare coverage. Methods: Focus groups with overall 34 patients/caregivers in three different Italian centers (from Northern, Centre, and Southern Italy) and an open-ended survey with 97 medical oncologists were undertaken. Transcripts from focus groups and the open-ended survey were analyzed to identify themes and links between themes. Themes from the qualitative research were supplemented with those reported in the literature; concepts identified formed the basis for item development that were then tested through the import...
Purpose: To identify a cut-off score for the COmprehensive Score for financial Toxicity (COST) to pr...
Pauge S, Surmann B, Mehlis K, et al. Patient-Reported Financial Distress in Cancer: A Systematic Rev...
Financial toxicity as an individual consequence of a cancer diagnosis currently evolves to a clinica...
Purpose: This paper illustrates a conceptual model for a new patient-reported outcome measure (PROM)...
Introduction Financial toxicity (FT) is a well-recognised problem in oncology. US-based studies have...
Background:Financial toxicity in cancer patients has been initially reported in the United States an...
Introduction. Financial toxicity (FT) is a well-recognized problem in oncology. US-based studies hav...
Objectives To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthc...
To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system ...
Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis...
Background: Cancer may cause financial difficulties, but its impact in countries with public health ...
BACKGROUND: Cancer may cause financial difficulties, but its impact in countries with public health...
AIM: As therapeutic options for cancer evolve and become more complex, the concept of financial toxi...
purpose: we investigated the association of financial toxicity (FT) with the health-related quality ...
The term ‘financial toxicity’ is broadly used to describe the distress or hardship arising from the ...
Purpose: To identify a cut-off score for the COmprehensive Score for financial Toxicity (COST) to pr...
Pauge S, Surmann B, Mehlis K, et al. Patient-Reported Financial Distress in Cancer: A Systematic Rev...
Financial toxicity as an individual consequence of a cancer diagnosis currently evolves to a clinica...
Purpose: This paper illustrates a conceptual model for a new patient-reported outcome measure (PROM)...
Introduction Financial toxicity (FT) is a well-recognised problem in oncology. US-based studies have...
Background:Financial toxicity in cancer patients has been initially reported in the United States an...
Introduction. Financial toxicity (FT) is a well-recognized problem in oncology. US-based studies hav...
Objectives To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthc...
To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system ...
Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis...
Background: Cancer may cause financial difficulties, but its impact in countries with public health ...
BACKGROUND: Cancer may cause financial difficulties, but its impact in countries with public health...
AIM: As therapeutic options for cancer evolve and become more complex, the concept of financial toxi...
purpose: we investigated the association of financial toxicity (FT) with the health-related quality ...
The term ‘financial toxicity’ is broadly used to describe the distress or hardship arising from the ...
Purpose: To identify a cut-off score for the COmprehensive Score for financial Toxicity (COST) to pr...
Pauge S, Surmann B, Mehlis K, et al. Patient-Reported Financial Distress in Cancer: A Systematic Rev...
Financial toxicity as an individual consequence of a cancer diagnosis currently evolves to a clinica...